- Home
- WIMI vs TLSA Comparison
WIMI vs TLSA Comparison
Compare WIMI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- TLSA
- Stock Information
- Founded
- WIMI 2015
- TLSA 2013
- Country
- WIMI China
- TLSA United Kingdom
- Employees
- WIMI N/A
- TLSA N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- TLSA Health Care
- Exchange
- WIMI Nasdaq
- TLSA Nasdaq
- Market Cap
- WIMI 94.3M
- TLSA 87.8M
- IPO Year
- WIMI 2020
- TLSA 2000
- Fundamental
- Price
- WIMI $1.27
- TLSA $0.82
- Analyst Decision
- WIMI
- TLSA
- Analyst Count
- WIMI 0
- TLSA 0
- Target Price
- WIMI N/A
- TLSA N/A
- AVG Volume (30 Days)
- WIMI 5.6M
- TLSA 396.2K
- Earning Date
- WIMI 01-01-0001
- TLSA 03-04-2025
- Dividend Yield
- WIMI N/A
- TLSA N/A
- EPS Growth
- WIMI N/A
- TLSA N/A
- EPS
- WIMI N/A
- TLSA N/A
- Revenue
- WIMI $84,137,968.00
- TLSA N/A
- Revenue This Year
- WIMI N/A
- TLSA N/A
- Revenue Next Year
- WIMI N/A
- TLSA N/A
- P/E Ratio
- WIMI N/A
- TLSA N/A
- Revenue Growth
- WIMI 19.25
- TLSA N/A
- 52 Week Low
- WIMI $0.63
- TLSA $0.41
- 52 Week High
- WIMI $2.92
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- WIMI 61.85
- TLSA 54.65
- Support Level
- WIMI $0.92
- TLSA $0.65
- Resistance Level
- WIMI $1.08
- TLSA $0.94
- Average True Range (ATR)
- WIMI 0.09
- TLSA 0.06
- MACD
- WIMI 0.04
- TLSA 0.02
- Stochastic Oscillator
- WIMI 73.35
- TLSA 61.26
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.